Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Free Cash Flow (2023 - 2025)

Rallybio's Free Cash Flow history spans 3 years, with the latest figure at -$6.6 million for Q3 2025.

  • For Q3 2025, Free Cash Flow rose 51.64% year-over-year to -$6.6 million; the TTM value through Sep 2025 reached -$35.0 million, up 31.47%, while the annual FY2024 figure was -$49.3 million, 18.24% up from the prior year.
  • Free Cash Flow for Q3 2025 was -$6.6 million at Rallybio, up from -$8.4 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$6.6 million in Q3 2025 and bottomed at -$18.8 million in Q1 2023.
  • The 3-year median for Free Cash Flow is -$11.6 million (2023), against an average of -$12.2 million.
  • The largest annual shift saw Free Cash Flow grew 15.31% in 2024 before it surged 51.64% in 2025.
  • A 3-year view of Free Cash Flow shows it stood at -$11.6 million in 2023, then rose by 15.31% to -$9.9 million in 2024, then soared by 33.58% to -$6.6 million in 2025.
  • Per Business Quant, the three most recent readings for RLYB's Free Cash Flow are -$6.6 million (Q3 2025), -$8.4 million (Q2 2025), and -$10.2 million (Q1 2025).